1. Home
  2. WNW vs KYTX Comparison

WNW vs KYTX Comparison

Compare WNW & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WNW
  • KYTX
  • Stock Information
  • Founded
  • WNW 2015
  • KYTX 2018
  • Country
  • WNW China
  • KYTX United States
  • Employees
  • WNW N/A
  • KYTX N/A
  • Industry
  • WNW Catalog/Specialty Distribution
  • KYTX
  • Sector
  • WNW Consumer Discretionary
  • KYTX
  • Exchange
  • WNW Nasdaq
  • KYTX NYSE
  • Market Cap
  • WNW 200.5M
  • KYTX 166.4M
  • IPO Year
  • WNW 2020
  • KYTX 2024
  • Fundamental
  • Price
  • WNW $0.37
  • KYTX $3.33
  • Analyst Decision
  • WNW
  • KYTX Buy
  • Analyst Count
  • WNW 0
  • KYTX 5
  • Target Price
  • WNW N/A
  • KYTX $23.20
  • AVG Volume (30 Days)
  • WNW 7.4M
  • KYTX 325.4K
  • Earning Date
  • WNW 11-15-2024
  • KYTX 02-12-2025
  • Dividend Yield
  • WNW N/A
  • KYTX N/A
  • EPS Growth
  • WNW N/A
  • KYTX N/A
  • EPS
  • WNW N/A
  • KYTX N/A
  • Revenue
  • WNW $380,345.00
  • KYTX N/A
  • Revenue This Year
  • WNW N/A
  • KYTX N/A
  • Revenue Next Year
  • WNW N/A
  • KYTX N/A
  • P/E Ratio
  • WNW N/A
  • KYTX N/A
  • Revenue Growth
  • WNW N/A
  • KYTX N/A
  • 52 Week Low
  • WNW $0.27
  • KYTX $3.24
  • 52 Week High
  • WNW $11.11
  • KYTX $30.60
  • Technical
  • Relative Strength Index (RSI)
  • WNW 32.38
  • KYTX 36.40
  • Support Level
  • WNW $1.64
  • KYTX $3.24
  • Resistance Level
  • WNW $3.50
  • KYTX $3.47
  • Average True Range (ATR)
  • WNW 0.67
  • KYTX 0.28
  • MACD
  • WNW -0.33
  • KYTX -0.02
  • Stochastic Oscillator
  • WNW 3.14
  • KYTX 8.82

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

Share on Social Networks: